Study of the Effects of Education on Patients With Chronic Obstructive Pulmonary Disease
2 other identifiers
interventional
42
1 country
2
Brief Summary
The investigators hypothesize that education will improve exercise capacity, symptoms and quality of life in patients with chronic obstructive pulmonary disease (COPD). In addition, the investigators are interested in determining how education might alter various chemicals in the blood and exhaled breath that reflect inflammation in the lungs and the body as a whole. The investigators plan to enroll 42 patients into this study, with half of them participating at each of the two sites, Vermont Lung Center at the University of Vermont in Burlington, Vermont, and at Baylor College of Medicine in Houston, Texas. Participants will undergo a series of measurements and tests at the beginning of the study, receive formal education about COPD over the next 2 weeks, return at 6 weeks for a brief refresher session, and finally return after 12 weeks for repeat measurement and testing as was done at the beginning. Participants will be asked to keep a diary of symptoms, medication, and exercise during the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2012
CompletedFirst Posted
Study publicly available on registry
July 4, 2012
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedNovember 4, 2020
November 1, 2020
3.2 years
June 29, 2012
November 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exercise tolerance
Exercise tolerance will be measured by 6 min walk distance at baseline and again after 12 weeks of the intervention
12 weeks
Secondary Outcomes (6)
Dynamic hyperinflation
12 weeks
Oxidative stress
12 weeks
Systemic inflammation
12 weeks
Lung mechanics
12 weeks
Dyspnea
12 weeks
- +1 more secondary outcomes
Study Arms (2)
Education-Pranayama
EXPERIMENTALSubjects will receive education about COPD with special attention to breathing techniques
Education-Control
SHAM COMPARATORSubjects will receive education alone about COPD.
Interventions
Specific yoga-related breathing method.
Eligibility Criteria
You may qualify if:
- Men and women, aged 18 and older, with a physician diagnosis of COPD
- COPD defined according to GOLD criteria, with FEV1/FVC \< 0.7, and FEV1 \< 80% predicted.
- Current non-smoker
- Stable medical regimen for COPD over last 4 weeks
- Stable physical activity over the last 4 weeks, with no plans for any change during the duration of the study
- MRC Dyspnea Scale \> 2
- Not planning to engage in any formal pulmonary rehabilitation program during the time of the study
- No use of any nutritional supplements other than standard multivitamins
You may not qualify if:
- Exacerbation of disease within previous 2 weeks
- Concomitant other respiratory disease or significant cardiovascular disease
- Previous practice of yoga
- Current use of antioxidant supplements (e.g., vitamin C, vitamin E, n-acetylcysteine)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Baylor College of Medicine
Houston, Texas, 77030, United States
Vermont Lung Center
Colchester, Vermont, 05446, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Kaminsky, MD
University of Vermont
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
June 29, 2012
First Posted
July 4, 2012
Study Start
September 1, 2012
Primary Completion
November 1, 2015
Study Completion
October 1, 2016
Last Updated
November 4, 2020
Record last verified: 2020-11